Brain Atrophy Rates for Stable Multiple Sclerosis Patients on Long-Term Fingolimod versus Glatiramer Acetate

Background: Clinically stable multiple sclerosis (MS) patients on long-term therapy often have negligible acute inflammation on MRI. Brain atrophy may provide insight into subclinical disease progression in such populations. Objective: This study aims to compare brain atrophy for age- and gender-mat...

Descripción completa

Detalles Bibliográficos
Autores principales: Honce, Justin M., Nair, Kavita V., Hoyt, Brian D., Seale, Rebecca A., Sillau, Stefan, Engebretson, Eric, Schurr, Brittany, Corboy, John R., Vollmer, Timothy L., Alvarez, Enrique
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7538802/
https://www.ncbi.nlm.nih.gov/pubmed/33071934
http://dx.doi.org/10.3389/fneur.2020.01045

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7538802/
https://www.ncbi.nlm.nih.gov/pubmed/33071934
http://dx.doi.org/10.3389/fneur.2020.01045

Ejemplares similares